Published in Neuroscientist on February 25, 2014
Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease. J Neurosci (2014) 0.91
Monoglyceride lipase: Structure and inhibitors. Chem Phys Lipids (2015) 0.82
Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury. J Cereb Blood Flow Metab (2014) 0.82
NO2 inhalation promotes Alzheimer's disease-like progression: cyclooxygenase-2-derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication. Sci Rep (2016) 0.78
Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents. J Neuroinflammation (2016) 0.77
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability. J Neurotrauma (2016) 0.77
The Endocannabinoid System as a Therapeutic Target in Glaucoma. Neural Plast (2016) 0.77
Homeostatic regulation of brain functions by endocannabinoid signaling. Neural Regen Res (2015) 0.77
Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy. Parkinsons Dis (2016) 0.75
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices. J Neuroimmune Pharmacol (2016) 0.75
Using Caenorhabditis elegans to Uncover Conserved Functions of Omega-3 and Omega-6 Fatty Acids. J Clin Med (2016) 0.75
A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by Modulating the Endocannabinoid System in HT22 Cells. Front Neurosci (2017) 0.75
A Comparative Analysis of the Endocannabinoid System in the Retina of Mice, Tree Shrews, and Monkeys. Neural Plast (2016) 0.75
The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models. Int J Mol Sci (2017) 0.75
Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (1992) 16.31
Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol (1973) 14.99
Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (1990) 13.60
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature (1998) 13.58
Molecular characterization of a peripheral receptor for cannabinoids. Nature (1993) 13.45
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature (1996) 8.99
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol (1995) 8.09
The endogenous cannabinoid system controls extinction of aversive memories. Nature (2002) 7.19
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun (1995) 6.55
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol (2007) 6.20
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature (2001) 6.12
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci (1991) 5.88
Role of endogenous cannabinoids in synaptic signaling. Physiol Rev (2003) 5.70
The three-dimensional organization of the hippocampal formation: a review of anatomical data. Neuroscience (1989) 5.58
Endocannabinoid-mediated control of synaptic transmission. Physiol Rev (2009) 5.56
Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A (1990) 5.48
Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A (2002) 5.33
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol (2008) 5.32
CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science (2003) 5.22
The spectrum of disease in chronic traumatic encephalopathy. Brain (2012) 5.10
A cortical-hippocampal system for declarative memory. Nat Rev Neurosci (2000) 4.95
Chronic traumatic encephalopathy in a National Football League player. Neurosurgery (2005) 4.67
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem (1995) 4.53
Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron (2003) 4.42
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature (2007) 4.36
Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron (2003) 4.32
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31
Endocannabinoid signaling in the brain. Science (2002) 4.28
Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron (2001) 4.15
Long-lasting potentiation of synaptic transmission in the dentate area of the unanaestetized rabbit following stimulation of the perforant path. J Physiol (1973) 4.12
Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci (2006) 3.95
Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature (2008) 3.94
Spike timing-dependent plasticity of neural circuits. Neuron (2004) 3.76
Organization of intrahippocampal projections originating from CA3 pyramidal cells in the rat. J Comp Neurol (1990) 3.67
Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol (2002) 3.59
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science (2011) 3.48
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci (2002) 3.34
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature (2001) 3.33
Cerebellar long-term depression: characterization, signal transduction, and functional roles. Physiol Rev (2001) 3.24
Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex. J Neurosci (2006) 3.00
Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci U S A (2002) 2.95
Chronic neuropathologies of single and repetitive TBI: substrates of dementia? Nat Rev Neurol (2013) 2.84
Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci (2010) 2.78
Impaired spatial representation in CA1 after lesion of direct input from entorhinal cortex. Neuron (2008) 2.72
Calcium entry increases the sensitivity of cerebellar Purkinje cells to applied GABA and decreases inhibitory synaptic currents. Neuron (1991) 2.68
Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol (2002) 2.59
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron (2006) 2.55
Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron (2004) 2.50
Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism. Chem Biol (2009) 2.48
Role for a cortical input to hippocampal area CA1 in the consolidation of a long-term memory. Nature (2004) 2.34
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci (2005) 2.31
Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci (2004) 2.25
Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J Neurosci (2002) 2.24
Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci (1992) 2.22
Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci (2005) 2.18
RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol (2004) 2.12
Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentata of the rat. J Comp Neurol (1976) 2.11
Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol (2007) 2.08
A biosynthetic pathway for anandamide. Proc Natl Acad Sci U S A (2006) 2.08
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci (2003) 2.04
Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci (2002) 2.02
The neuropathology and neurobiology of traumatic brain injury. Neuron (2012) 1.99
Lamellar organization of hippocampal pathways. Exp Brain Res (1971) 1.99
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci (2004) 1.93
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat Neurosci (2005) 1.92
Endocannabinoid signaling and synaptic function. Neuron (2012) 1.90
Cannabis: pharmacology and toxicology in animals and humans. Addiction (1996) 1.89
A light and electron microscopic analysis of the mossy fibers of the rat dentate gyrus. J Comp Neurol (1986) 1.88
Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat Neurosci (2002) 1.84
Direct cortical input modulates plasticity and spiking in CA1 pyramidal neurons. Nature (2002) 1.83
Endocannabinoids control the induction of cerebellar LTD. Neuron (2005) 1.81
Laminar selectivity of the cholinergic suppression of synaptic transmission in rat hippocampal region CA1: computational modeling and brain slice physiology. J Neurosci (1994) 1.81
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging (2009) 1.77
Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther (2009) 1.74
Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci (2004) 1.70
Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS One (2007) 1.67
Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol Pharmacol (2005) 1.66
CB2 receptors in the brain: role in central immune function. Br J Pharmacol (2007) 1.66
Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol (2013) 1.60
Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron (1994) 1.59
Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling. Cell (2013) 1.58
A role for synaptic inputs at distal dendrites: instructive signals for hippocampal long-term plasticity. Neuron (2007) 1.53
The clinical spectrum of sport-related traumatic brain injury. Nat Rev Neurol (2013) 1.49
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids (2002) 1.48
Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol Pharmacol (2009) 1.46
Acute and chronic traumatic encephalopathies: pathogenesis and biomarkers. Nat Rev Neurol (2013) 1.43
The cannabinoid receptor: biochemical, anatomical and behavioral characterization. Trends Neurosci (1990) 1.42
PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms. Brain Res (2008) 1.41
Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology (2009) 1.39
Endocannabinoid signaling in microglial cells. Neuropharmacology (2008) 1.36
Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol (2004) 1.35
Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem (2005) 1.34
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. Mol Pharmacol (2006) 1.34
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J (2000) 1.32
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci (2006) 1.28
Endocannabinoids and synaptic function in the CNS. Neuroscientist (2007) 1.27
The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications. CNS Drugs (2008) 1.26
Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease. Cell Rep (2012) 1.25
Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region. J Neurosci (1999) 1.25